4mg Lenvatinib Capsules IP is a medication used in the treatment of certain types of cancer, notably thyroid cancer and kidney cancer. This refers to a formulation of lenvatinib that complies with the standards set by the Indian Pharmacopoeia (IP). It is a type of targeted therapy known as a tyrosine kinase inhibitor, which works by blocking the action of specific enzymes involved in the growth and spread of cancer cells. By blocking these pathways, lenvatinib helps to inhibit angiogenesis and slow down the growth and spread of cancer cells. 4mg Lenvatinib Capsules IP works by inhibiting the activity of multiple receptor tyrosine kinases, including VEGFR (vascular endothelial growth factor receptor), FGFR (fibroblast growth factor receptor), and PDGFR (platelet-derived growth factor receptor).
Other details
Brand | Lenvatol 4 |
Manufacturer | Cipla |
Strength: | 4 mg |
Use | Oral use |
Strength | 12 mg |
Price: